Evidence map›Paper›PMID 40686646›Full record

ReviewRSC advances2025

Micelle-driven organic synthesis: an update on the synthesis of heterocycles and natural products in aqueous medium over the last decade.

Mohmad Muzafar Wani, Bilal A Bhat

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohmad Muzafar WaniNatural Products and Medicinal Chemistry, CSIR-Indian Institute of Integrative Medicine Sanat Nagar Srinagar 190005 India.
Bilal A BhatNatural Products and Medicinal Chemistry, CSIR-Indian Institute of Integrative Medicine Sanat Nagar Srinagar 190005 India.ORCID https://orcid.org/0000-0002-0239-7625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organic synthesis guided by micellar nanoreactors constitutes one of the fundamental fields of organic chemistry that is expected to furnish chemical synthesis in a sustainable fashion. Due to its promise, we were also attracted to using the micelles to enhance chemical reactivity and selectivity and to explore their newer applications in natural products and heterocyclic chemistry. As on date, there is no comprehensive review article that highlights the repertoire of chemical reactions developed in micelles furnishing a range heterocycles and natural products/scaffolds, barring the metal-catalyzed cross-coupling reactions. In this review, we document the last decade (2014-2024) progress of organic reactions developed in micelles to yield a range of heterocyclic and natural product-based scaffolds. Notably, we have excluded the content related to metal-catalyzed cross-coupling reactions and some other aspects of micelles due to the number of overlapping reviews written on such topics. In the current article, we briefly introduce micellar catalysis, regions of reaction sites in micelles, and various surfactants utilized in micelle chemistry. Our discussion also captures the importance of micellar catalysis compared to the conventional organic synthesis. More importantly, the focus of our review is largely on the collection of chemical transformations accomplished in the last decade in accessing heterocycles and natural products to showcase the advancement of organic synthesis through sustainable fashion. Wherever required, we have also captured the various interactions of surfactants with the substrates necessary for driving the reactions and discussed the importance of these heterocycles/natural products in intercepting the key biological pathways.

Identifiers

PMID40686646
PMCPMC12272565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.